Biotech firm Aura Biosciences locks in $40 mln Series D
Cambridge, Massachusetts-based Aura Biosciences, a biotechnology company, has secured $40 million in Series D financing. Medicxi led the round.
2 April 2019•1 min read
Cambridge, Massachusetts-based Aura Biosciences, a biotechnology company, has secured $40 million in Series D financing. Medicxi led the round.
